Pages that link to "Q52293860"
Jump to navigation
Jump to search
The following pages link to Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: Health, developmental, and social implications (Q52293860):
Displaying 50 items.
- Developmental consequences of fetal exposure to drugs: what we know and what we still must learn (Q30395013) (← links)
- The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. (Q31870918) (← links)
- Early development of infants exposed to drugs prenatally. (Q33600816) (← links)
- Substance use in pregnancy (Q33876020) (← links)
- SOGC clinical practice guidelines: Substance use in pregnancy: no. 256, April 2011 (Q34003615) (← links)
- Management of drug addict pregnant women and their children (Q34064741) (← links)
- Review of the assessment and management of neonatal abstinence syndrome (Q34199044) (← links)
- Maternal HIV and drug use: effect on health and social morbidity (Q34797714) (← links)
- Central and autonomic system signs with in utero drug exposure (Q35292284) (← links)
- Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome? (Q35295236) (← links)
- Perinatal substance abuse (Q35441794) (← links)
- Behaviour in first year after drug dependent pregnancy (Q35624226) (← links)
- Developmental and behavioral consequences of prenatal drug and alcohol exposure (Q36694728) (← links)
- Treatment Issues for Opioid-Dependent Women During the Perinatal Period (Q36894273) (← links)
- Treatment of opioid-dependent pregnant women: clinical and research issues (Q37076673) (← links)
- Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study (Q37230564) (← links)
- Evaluation and management of opioid dependence in pregnancy (Q37632852) (← links)
- Prenatal exposure to methadone and buprenorphine: A review of the potential effects on cognitive development (Q37863863) (← links)
- Neuropeptide influences on the development of their receptors (Q38192593) (← links)
- Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis (Q38242505) (← links)
- Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine (Q38402261) (← links)
- Opiates, endorphins and the developing organism: A comprehensive bibliography (Q38583910) (← links)
- Potential human developmental toxicants and the role of animal testing in their identification and characterization (Q38625359) (← links)
- Deleterious effects of drugs on the developing nervous system. (Q38657897) (← links)
- Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review (Q38754158) (← links)
- Fetal Drug Exposure—Behavioral Teratogenesis (Q40109250) (← links)
- Psychological characteristics and development of narcotic-addicted infants (Q40109545) (← links)
- Effects of drugs and chemicals on the fetus and newborn (1). (Q40187779) (← links)
- Behavioral development in children prenatally exposed to drugs and alcohol (Q40385865) (← links)
- Treatment programming for alcohol and drug-dependent pregnant women (Q40807839) (← links)
- Effects of alcohol and other drugs on children (Q41436737) (← links)
- A longitudinal study of offspring born to methadone-maintained women. I. Design, methodology, and description of women's resources for functioning (Q41576722) (← links)
- Opioid dependence during pregnancy. Effects and management (Q41740838) (← links)
- Neonatal opiate abstinence syndrome in term and preterm infants (Q41971909) (← links)
- Children of methadone-maintained mothers: Follow-up to 18 months of age (Q42243260) (← links)
- In contrast to cocaine, prenatal exposure to methadone does not produce detectable alterations in the developing mouse brain (Q42539774) (← links)
- Differences between dropouts and active participants in a pediatric clinic for substance abuse mothers (Q43496659) (← links)
- Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service (Q43525411) (← links)
- Risks and realities: Dyadic interaction between 6-month-old infants and their mothers in opioid maintenance treatment (Q44330082) (← links)
- Cessation of drug use and infant birth weight (Q47286576) (← links)
- Prenatal methadone exposure is associated with altered neonatal brain development (Q47366735) (← links)
- The effect of chronic methadone treatment on intra-uterine growth of the cynomolgus monkey (Macaca fascicularis). (Q52267372) (← links)
- A comprehensive care program for pregnant addicts: obstetrical, neonatal, and child development outcomes (Q52275246) (← links)
- Buprenorphine and pregnancy. Analysis of 24 cases (Q52277718) (← links)
- Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood. (Q52563782) (← links)
- Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy. (Q53035028) (← links)
- Effects of in utero exposure to street drugs (Q57953920) (← links)
- A Longitudinal Study of Offspring Born to Methadone-Maintained Women. II. Dyadic Interaction and Infant Behavior at 4 Months (Q58175563) (← links)
- A Longitudinal Study of Offspring Born to Methadone-Maintained Women. III. Effects of Multiple Risk Factors on Development at 4, 8, and 12 Months (Q58296575) (← links)
- Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis (Q61414371) (← links)